The clinical trial, known as the CDK4/6 Inhibitor Dosing Knowledge Study, is investigating personalized dosing strategies for a common drug used to treat metastatic breast cancer in older patients.
Augusta Technical College President Dr. Jermaine Whirl has been named the sole finalist in a search for the new president of ...